GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Forward PE Ratio

Nanalysis Scientific (TSXV:NSCI) Forward PE Ratio : 0.00 (As of Jun. 10, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Forward PE Ratio?

Nanalysis Scientific's Forward PE Ratio for today is 0.00.

Nanalysis Scientific's PE Ratio without NRI for today is 0.00.

Nanalysis Scientific's PE Ratio for today is 0.00.


Nanalysis Scientific Forward PE Ratio Historical Data

The historical data trend for Nanalysis Scientific's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Forward PE Ratio Chart

Nanalysis Scientific Annual Data
Trend 2021-12 2022-12 2023-02
Forward PE Ratio
58.14 17.01 16.26

Nanalysis Scientific Quarterly Data
2021-12 2022-03 2022-06 2022-09 2022-12
Forward PE Ratio 58.14 62.50 86.21 21.23 17.01

Competitive Comparison of Nanalysis Scientific's Forward PE Ratio

For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanalysis Scientific's Forward PE Ratio Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Nanalysis Scientific's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Nanalysis Scientific's Forward PE Ratio falls into.



Nanalysis Scientific Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Nanalysis Scientific  (TSXV:NSCI) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Nanalysis Scientific Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanalysis Scientific (TSXV:NSCI) Business Description

Traded in Other Exchanges
Address
Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3
Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.
Executives
Michal Okoniewski Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines